SARS-CoV-2 Protease Inhibitors: An Attractive Approach for Treating COVID-19
PerkinElmer
JUNE 3, 2022
Inhibiting SARS-CoV-2 Proteases Currently, limited therapeutic options are available to those who are infected with SARS-CoV-2 and attempts to repurpose approved drugs have shown minimal success so far. The second virtual screen focused on optimization of a hit from a previous crystallographic fragment screen.
52 
Let's personalize your content